CMP Pharmaceuticals | CaroSpir®
Providing specialty niche liquids for acute care needs
CMP Pharma develops, manufactures and commercializes specialty pharmaceuticals, focused on niche oral liquid, injectable and topical products that solve unmet patient needs. CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL) is the first and only FDA-approved oral Suspension of the potassium-sparing diuretic spironolactone.
CaroSpir Educational Brochure
CaroSpir Full Prescribing Information
Scavenger Hunt Key Phrase: Liquid Approval